Top 5 Safest Companies To Own In Right Now

DIVIDEND SPOTLIGHT

New Best Buy Pick in Telecommunications

By Richard Stavros

At 7.48%, this U.K.-based communications company is the new Best Buy in my conservative portfolio (which is made up of 10 safety-rated stocks).

With a solid base of over 100 million customers in Europe, they��e well positioned to safely expand globally. They��e conquering new markets by onboarding millions of customers in India, Turkey, and across Africa.

I continue to watch U.S.-based Verizon (NYSE:VZ); more updates later. I don�� currently recommend Spain-based Telef贸nica (NYSE:TEF), as Robert outlines below.

My Best Buy is without a doubt the safest dividend in telecommunications ��find out more here.

FEATURE INCOME ARTICLE

Go Global, But Don�� Go Crazy

By Robert Frick

Our credo here at Global Income Edge is you collect the best returns by going global��ut by best we also mean relatively safe. Simply chasing the highest yields without weighing risks can land you in some shaky investments.

Best International Companies To Own For 2015: Panasonic Manufacturing Philippines Corp (PMPC)

Panasonic Manufacturing Philippines Corporation is a manufacturer, importer and distributor of electronic, electrical, mechanical, electro-mechanical appliances, other types of machinery, parts and components, battery, and other related products bearing the PANASONIC brand. The Company operates in three business segments: Global Consumer Marketing Sector (GCMS), System Network and Communication (SNC) and others. GCMS segment includes audio, video primarily related to selling products for media and entertainment industry. This also includes home appliance and household equipment primarily related to selling for household consumers. SNC segment includes office automation equipment such as telecommunication products, security system and projectors primarily related to selling for business consumers. Others segment includes supermarket refrigeration such as cold room, showcases and bottle coolers primarily related to selling to supermarkets and groceries. Advisors' Opinion:

• [By Suravi Thacker]

  Further, Tesla has some amazing plans for the future, which will make investors even more confident about the company. First, it has entered into partnership with Panasonic�(PMPC), the battery maker, to participate in setting up Gigafactory, the world�� largest battery factory in the U.S. This lithium ion battery factory will produce battery cells for 500,000 electronic vehicles on an annual basis. This initiative requires an investment of $5 billion and a total of 6,500 employees.

Top 5 Safest Companies To Own In Right Now: Financial Institutions Inc.(FISI)

Financial Institutions, Inc. operates as the holding company for Five Star Bank that provides consumer and commercial banking, and financial services to individuals, municipalities, and businesses in central and western New York. Its deposit accounts consist of noninterest-bearing demand, interest-bearing demand, savings, money market, club, individual retirement, and other qualified plan accounts, as well as certificates of deposit. The company?s loan portfolio comprises commercial loans, commercial real estate loans, one-to-four family residential mortgages, consumer automobile loans, recreational vehicle loans, boat loans, home improvement loans, closed-end home equity loans, home equity lines of credit, collateralized and uncollateralized personal loans, deposit account collateralized loans, commercial and agricultural working capital and revolving lines of credit, commercial and agricultural mortgages, equipment loans, and crop and livestock loans. It operates throug h a network of approximately 51 offices and 70 ATMs in 14 contiguous counties of western and central New York. The company, through its other subsidiary, Five Star Investment Services, Inc., provides brokerage services. Financial Institutions, Inc. was founded in 1931 and is based in Warsaw, New York.

Advisors' Opinion:

• [By Jon C. Ogg]

  Financial Institutions Inc. (NASDAQ: FISI) was started as Buy with a $24 price target by Sterne Agee.

  Ross Stores Inc. (NASDAQ: ROST) was reiterated as Buy and added to the prized Conviction Buy list at Goldman Sachs.

• [By GURUFOCUS]

  Financial Institutions Inc. (FISI) operates as the holding company for Five Star Bank that provides various banking and financial services to individuals, municipalities, and businesses. Aug. 21, the company increased its quarterly dividend 6% to $0.19 per share. The dividend is payable payable Oct. 2, 2013 to shareholders of record as of Sept. 12, 2013. The yield based on the new payout is 3.9%.

Top 5 Safest Companies To Own In Right Now: MiMedx Group Inc (MDXG)

MiMedx Group, Inc. (MiMedx), incorporated on February 28, 2008, is an integrated developer, manufacturer and marketer of regenerative biomaterial products processed from human amniotic membrane. The Company�� biomaterial platform technologies include the device technologies HydroFix and CollaFix, and tissue technologies, AmnioFix and EpiFix. Its tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through the Company�� donor program, mothers delivering full-term caesarian births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. MiMedx processes the human amniotic membrane utilizing its Purion Process to produce a manipulated implant for homologous use. MiMedx is the supplier of amniotic tissue, having supplied over 100,000 implants to distributors and other equipment manufacturers (OEMs) for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

The Company has three platform technologies. Its largest addressable market is in chronic wound care consisting of diabetic, venous and pressure ulcers. On January 5, 2011, the Company acquired all of the outstanding equity interests in Surgical Biologics, LLC. Located in Kennesaw, Georgia, Surgical Biologics develops allografts and other products processed from human amniotic membrane that can be used for a range of medical applications, including ocular surface repair, gum repair, wound care, nerve and tendon repair, spine repair, burn treatment, and many other types of procedures that require the repair of a patient�� integumental (native) tissue. Surgical Biologics has developed a specialized process for the processing of amniotic membrane to produce a manipulated allograft for homologous use.

AmnioFix and EpiFix

MiMedx is the supplier of allografts processed from amniotic tissue, having supplied over 70,000 allografts to date for application in the Ophthalm! ic, Orthopedic, Dental, Spinal and Wound Care segments of healthcare. Its amnion products, AmnioFix and EpiFix, are processed from human tissue. The AmnioFix and EpiFix allografts can be used for a range of procedures, including ocular surface repair, gingival recession repair, wound care, burns, and many other types of procedures for the repair of a patient�� integumental (native) tissue. Its AmnioFix technology also is used as a graft to reduce the amount of scar tissue formation, provide a local anti-inflammatory and help with the soft tissue healing of the area. EpiFix offers a range of wound healing and wound care options. Much of the clinical usage of EpiFix has been for wound care patients suffering from diabetic ulcers, pressure ulcers, vein circulation ulcers, or artery circulation ulcers.

CollaFix

The Company�� CollaFix technology combines a means of creating fibers from soluble collagen and a specialized cross-linking process. MiMedx utilizes two separate cross-linking technologies for various applications. Initial laboratory and animal testing shows that the cross-linked collagen fibers produce a biocompatible, and durable construct that can be transformed into surgical meshes intended to treat a number of orthopedic soft-tissue trauma and disease disorders.

HydroFix

The Company licenses rights to a polyvinyl alcohol (PVA) polymer, which is a water-based biomaterial that can be manufactured with a range of mechanical properties, including those that appear to mimic closely the mechanical and physical properties of natural, healthy human tissue. This hydrogel has been used in other orthopedic and general surgery device applications, and it has demonstrated biocompatibility and durability inside the human body. It has a similar version of the product for the European market called HydroFix Spine Shield. The device is classified as a post-surgical adhesion inhibiting barrier and is used in specific spine surgeries. In December the original! HydroFix! Spine Shield (for Anterior use Class IIb in Europe) was renamed to be HydroFix Anterior Shield.

The Company competes with W.L. Gore & Associates, Inc. and Stryker.

Advisors' Opinion:

• [By Rich Smith]

  MiMedx Group (NASDAQ: MDXG  ) ,�announced�Monday that results from a randomized controlled trial for its EpiFix wound-care allograft have been published in the International Wound Journal.�
  
  The clinical trial included patients with diabetic foot ulcers of at least four weeks' duration without infection, having adequate blood supply. Patients were broken into two groups, one receiving standard care alone, the other standard care plus EpiFix. After four and six weeks of treatment, the overall healing rate of patients treated with EpiFix was 77% and 92%, respectively, whereas standard care healed 0% and 8% of the wounds, respectively. The rate of healing with EpiFix exceeded that of standard treatment as well.
  
  According to the World Health Organization, diabetes will affect 366 million people worldwide -- up from 171 million in 2000.�Approximately 25% of diabetics will develop a chronic non-healing ulcer over their lifetime.�Diabetic foot ulcers�occur in 15% of all patients with diabetes and precede 84% of all lower leg amputations.
  
  EpiFix makes use of dehydrated human amniotic membrane to heal these ulcers. At room�temperature, EpiFix can have a shelf life of five years and retains the properties of the natural membrane.�Although there are similar, competing products on the market, the superior performance of�EpiFix compared with rival products (not yet proven by published studies) could help to make the company a market leader in the treatment of diabetic foot ulcers.

Top 5 Safest Companies To Own In Right Now: NeuroMetrix Inc.(NURO)

NeuroMetrix, Inc., a science-based health care company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with diabetes, carpal tunnel syndrome, lumbosacral disc disease, and spinal stenosis. The company focuses on diagnosis and treatment of the neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include the ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the diagnosis and evaluation of CTS, low back and leg pain, and DPN; and the NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care, as well as consumables and accessories for use with its neurodiagnostic equipment. The company is also developing SENSUS pain therapy device, a transcutaneous electrical nerve stimul ator used in the management of chronic pain, such as that caused by DPN; and ADVANCE CTS, a version of the ADVANCE NCS/EMG device for the detection of CTS in people with diabetes. The company distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, and hospitals consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology/podiatry market in the United States and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:

• [By Bryan Murphy]

  If you missed the recent surges from Neurometrix Inc. (NASDAQ:NURO) and/or OXiGENE Inc. (NASDAQ:OXGN), and decided to skip an entry on either or both because they were too frothy at the time, then here's some good news.... you're getting a second chance. Both NURO and OXGN are getting their proverbial second wind, and they're doing so at a price much lower than the price you would have had to pay for either just a few days ago. There's just one catch - you may want to hurry of you want in. This second wind is unfurling as rapidly as the first surges did.